Navigation Links
Novartis Pharmaceuticals Corporation Prevails in Medicaid Pricing Case Before Alabama Supreme Court
Date:10/16/2009

EAST HANOVER, N.J., Oct. 16 /PRNewswire/ -- The Alabama Supreme Court today overturned a jury verdict against Novartis Pharmaceuticals Corporation (NPC), and directed entry of judgment in favor of NPC. NPC is pleased that the Alabama Supreme Court has found in our favor, which demonstrates that the State of Alabama's claims were unfounded. The State of Alabama had claimed that the prices provided by NPC to reporting services resulted in overpayment to pharmacists and doctors in the Alabama State Medicaid system, and a Montgomery County Circuit Court jury initially found NPC liable.

NPC was among 73 pharmaceutical manufacturers named in a lawsuit filed in 2005 by the Alabama Attorney General. Through the appeal process, NPC demonstrated that it reported true and accurate prices, based on terms that have been known and used by all participants in pharmaceuticals markets, including Alabama Medicaid, for more than 30 years.

"We're pleased by the Alabama Supreme Court's ruling today," said Ludwig Hantson, PhD, Head of Pharma North America, CEO, Novartis Pharmaceuticals Corporation. "NPC is committed to high ethical standards in the pricing, marketing and sale of all of our products."

NPC's mission is to help patients and provide access to medications that treat disease, ease suffering and improve people's lives. In 2008 alone, NPC provided approximately $4.1M in prescription drugs to over 2,100 low-income Alabamans through our Patient Assistance Program.

Disclaimer

The foregoing release contains forward-looking statements that can be identified by express or implied discussions regarding the potential outcome of any other pricing litigation. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
2. Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting
3. Emisphere Announces Recruitment of Novartis Phase III Study for Oral Osteoporosis Treatment
4. Video: Novartis Vaccines and PTA Battle Flu: Public Health Vaccination Initiative Urges Families Lets Fight Flu Together!
5. More Than 200 Abstracts at ASH and SABCS Reveal Potential Compelling Patient Benefits From Novartis Oncology Current and Pipeline Therapies
6. Video: Data on More Than 15 Novartis Oncology Compounds at ASCO Highlight Progress Toward Targeted Therapies for Diverse Tumor Types
7. Juvenile Diabetes Research Foundation, The Genomics Institute of the Novartis Research Foundation Announce Innovative Diabetes Drug Discovery and Development Partnership
8. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
9. Results In The New England Journal Of Medicine Confirm Novartis Drug Femara(R) Is Superior To Tamoxifen After Breast Cancer Surgery
10. Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt(TM), an FDA-Approved Oral Therapy for Schizophrenia
11. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... -- Building on the momentum of the first quarter of 2015, ... systems, has announced aggressive plans to expand its Medicaid Home ... business models. The first quarter addition of new ... and Louisiana is a ... statewide coverage in each state. This brings the total to ...
(Date:3/30/2015)... A team of Chinese and US scientists has determined ... plays a critical role in thrombosis, or blood clot, ... which challenge the conventional concepts of drug action at ... for future drug discovery. In a paper ... researchers at Shanghai Institute of Materia Medica ...
(Date:3/30/2015)... 30, 2015  Cochlear Corporation Vice President of ... Cochlear to join Valencia Technologies ( www.valenciatechnologies.com ) ... Greiner , who is the CEO of Valencia.  ... and will be responsible for generating enthusiasm and ... coin-sized neuromodulation device in the treatment ...
Breaking Medicine Technology:MedScope's Aggressive 2015 Expansion Focuses on Medicaid Waiver and Managed Care Organizations 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 2New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 3New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 4New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 5New Molecular Structures Challenge Conventional Concepts of Drug Action at Receptors 6Cochlear VP of U.S. Sales Jerry Schloffman Accepts Chief of Market Development Position at Valencia Technologies 2
... Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix ... the publication of an article in the June ... protection from mucosal and systemic ricin intoxication by intradermal ... ricin toxin. The article was authored by the Company,s ...
... SEATTLE , June 25 Two ... , the Infectious Disease Research Institute (IDRI) and PATH, ... novel adjuvants for their ability to enhance the immune ... supports the goal of PATH,s influenza vaccine project to ...
Cached Medicine Technology:Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 2Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 3Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 4Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 5Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 6Soligenix Announces Publication of Positive Data Describing Protection from Mucosal and Systemic Ricin Intoxication by Intradermal RiVax™ Administration 7IDRI and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines 2IDRI and PATH Enter into Research Collaboration Agreement to Evaluate Novel Adjuvants to Enhance Pandemic Influenza Vaccines 3
(Date:3/31/2015)... MO (PRWEB) March 31, 2015 ... University maternal-fetal medicine specialists at Barnes-Jewish Hospital to ... of the Southern Illinois Healthcare (SIH) system. , ... area needed a maternal-fetal medicine consultation, she had ... get an ultrasound and then talk with a ...
(Date:3/30/2015)... March 31, 2015 Phoenix Strategic Performance, ... announces the launch of the PSP Institute. The ... learning and development with a direct connection to applied ... the original work of the Phoenix Strategic Performance Assessment ... assessment platform is in an organization’s ability to take ...
(Date:3/30/2015)... 2015 NAPW honors ... of the Year. Ms. Lucht is recognized with this ... most-recognized networking organization of professional women in the country, ... of Professional Women is a powerfully vibrant networking community ... , “Today’s managers need to have leadership skills and ...
(Date:3/30/2015)... 2015 The AAAHC, a private, ... the provision of high-quality health care through the ... and accreditation programs for 35 years. Through a ... to promote excellence in patient safety and care. ... and on-site evaluations by AAAHC expert surveyors, doctors, ...
(Date:3/30/2015)... March 30, 2015 Foundations Recovery Network, ... announce the start of its 41st national conference by ... McGonigal, and former Congressman Patrick J. Kennedy as keynote ... being held in San Diego, CA, March 30 - ... national conference brings together leading experts specializing in the ...
Breaking Medicine News(10 mins):Health News:Access to Maternal-fetal Experts Expands into Rural Communities 2Health News:Access to Maternal-fetal Experts Expands into Rural Communities 3Health News:Phoenix Strategic Performance Launches Human Capital Development Institute 2Health News:Phoenix Strategic Performance Launches Human Capital Development Institute 3Health News:National Association of Professional Women Announces Winifred K. Lucht, Patient Financial Services Manager at Marshfield Clinic, a 2015 Professional Woman of the Year 2Health News:Precinct Ambulatory Surgery Center Achieves Accreditation Association for Ambulatory Health Care Accreditation 2Health News:Foundations Recovery Network Kicks Off Its 41st National Conference Specializing in the Treatment of Substance Abuse and Behavioral Health 2
... studies to test its treatment against Herpes Keratitis, when the ... that the treatment did not prove successful when tested on ... the efficacy of QR-435 in quelling the virus showed that ... period required to kill the virus. But during many other ...
... cough up 61 million U.S. dollars to take the anti-bird flu ... in the budget for 2007 as// compared to the spending allocated ... National Committee for bird flu control, Bayu Krishnamurthi, the added spending ... anti bird flu drive. So far there have been 74 human ...
... done it. Eating fish while expecting has been considered healthy, ... ,A study, to be published in the British Journal ... women into their 24 Th week. Amounts of mercury in ... the fetuses were noted to be way ahead of the ...
... while cholesterol-lowering drugs do increase the risk of painful ... rare//, according to Sonal Singh, M.D., from Wake Forest ... is a fairly common condition and cholesterol-lowering drugs have ... of people around the world take these drugs, our ...
... not individuals – are critical to the prevention of ... health, safety//, and welfare of patients, according to an ... today’s issue of the New England Journal of Medicine. ... of devices and catheters to deliver intravenous fluids and ...
... says, New Yorkers are less likely to die of a ... has the second-highest death rate from coronary// heart disease. ... 2003, only 35 of every 100,000 New York residents died ... heart disease. ,Oklahoma leads with 228. Hawaii had ...
Cached Medicine News:Health News:Nothing Fishy About This 2Health News:Risk of Acute Pancreatitis Low With Statins 2Health News:Medical Teams Are Key to Patient Safety 2
Foreign body spud angled, lightly rounded tip....
Foreign body spud very thin, lightly curved and rounded tip....
... Night & Day soft contact lenses can ... the cornea and to relieve corneal pain ... ocular pathologies such as bullous keratopathy, corneal ... as well as post-surgical conditions resulting from ...
Guthrie skin hook with 2 prongs....
Medicine Products: